EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation - Seizer, Peter; Schönberger, Tanja; Schött, Moritz; R. Lang, Michael; Langer, Harald F.; Bigalke, Boris; Krämer, Björn F.; Borst, Oliver; Daub, Karin; Heidenreich, Olaf; Schmidt, Roland; Lindemann, Stephan; et al. (Atherosclerosis, 2010)
Keywords: Animals; Antigens, CD34 - metabolism; Apolipoproteins E - genetics; Atherosclerosis; Atherosclerosis (general aspects, experimental research); Atherosclerosis - metabolism; Atherosclerosis - pathology; Basigin - metabolism; Biological and medical sciences; Blood and lymphatic vessels; Cardiology. Vascular system; Cardiovascular; CD34+ progenitor cells; Cell Differentiation; Cell Movement; Collagen; Cyclophilin A - antagonists & inhibitors; Cyclophilin A - metabolism; Cyclophylin A; Cyclosporine - pharmacology; Diseases of the cardiovascular system; Drug Combinations; EMMPRIN; Foam cells; Foam Cells - metabolism; Foam Cells - pathology; Humans; Laminin; Ligands; Macrophage Colony-Stimulating Factor - metabolism; Macrophages - cytology; Macrophages - metabolism; Matrix Metalloproteinase 14 - metabolism; Matrix Metalloproteinase 9 - metabolism; Medical sciences; Mice; Mice, Mutant Strains; MMPs; Proteoglycans; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Stem Cells - metabolism; Stem Cells - pathology; EMMPRIN; CD34+ progenitor cells; Cyclophylin A; Foam cells; MMPs; Atherosclerosis; CD34 + progenitor cells; Vascular disease; Cardiovascular disease; progenitor cells; Foam cell; Cerebrospinal fluid; CD34; Progenitor cell